Giddy Holdings, Inc. – Trademark Portfolio
Entity Type: 03
Giddy Holdings, Inc. holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 13 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include EDDIE and GIDDY. The owner is based in Austin, TX.
1005 E. St. Elmo Road, Bldg. 10
Austin, TX 78745
Showing of trademarks Trademarks
Trademark Classifications
Giddy Holdings, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Giddy Holdings, Inc. have?
Giddy Holdings, Inc. has 15 U.S. trademarks filed with the USPTO. Of these, 2 registered, 13 abandoned.
What trademark classes does Giddy Holdings, Inc. file in?
Giddy Holdings, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Giddy Holdings, Inc.'s most well-known trademarks?
Giddy Holdings, Inc.'s registered trademark portfolio includes well-known marks such as EDDIE and GIDDY. These are among 2 currently registered trademarks in the portfolio.
What is Giddy Holdings, Inc.'s trademark registration success rate?
Giddy Holdings, Inc. has a 13% trademark registration rate, with 2 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.